In this study, we have demonstrated TXNIP’s anticancer effects in MDA-MB-231 (high endogenous TXNIP) and HCC-1954 (low endogenous TXNIP) breast cancer cells. The gene discussed is TXNIP; the disease is breast carcinoma.